Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 981 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-05-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-04-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The document is extremely short (under 5000 characters) and merely states that an announcement has been published elsewhere, without containing any substantive content or data. This fits the criteria of an RPA (Report Publication Announcement) rather than the report itself.
2026-04-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The document is extremely short (242 characters) and simply states that an announcement has been published elsewhere. It does not contain substantive financial data or details of a specific filing but merely informs readers that a report is available. This fits the definition of a Report Publication Announcement (RPA) rather than a substantive report or other category.
2026-04-28 English
(1) PROPOSED APPOINTMENT OF DIRECTORS OF THE FOURTH SESSION OF THE BOARD; (2) PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION BY VIRTUE OF THE CHANGE IN BOARD COMPOSITION; AND (3) CHANGES IN ACCOUNT
Board/Management Information Classification · 1% confidence The document is a corporate announcement under Hong Kong Listing Rules detailing proposed appointments and resignations of directors, amendments to the Articles of Association related to board composition, and changes in accounting policies. It is primarily an announcement of board/management changes (and related governance amendments), rather than a full financial report or dividend/financing notice. Therefore, the most appropriate category is Board/Management Information (MANG).
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.